Back to Search
Start Over
Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite.
- Source :
-
Clinics in podiatric medicine and surgery [Clin Podiatr Med Surg] 2000 Oct; Vol. 17 (4), pp. 715-22. - Publication Year :
- 2000
-
Abstract
- Frostbite injury to the extremities has the potential for disastrous effects. Prompt recognition and treatment are paramount. The use of Pentoxifylline to minimize tissue damage in the treatment of frostbite is a viable addition to the traditional therapy of rewarming soaks, pain management, and vesicle débridement. The most well known action of Pentoxifylline is its ability to increase RBC flexibility, allowing easier vascularization. This explains its indication for PVD, arterial disease, and intermittent claudication. As is explained previously, however, Pentoxifylline has multiple actions that will enhance tissue survival. The dosage of Pentoxifylline in controlled release tablet form is one 400 mg tablet three times a day with meals. The duration of treatment should be from two to six weeks. As this drug has many actions and therefore possibilities, more research is warranted with regards to its use not only with frostbite, but with other pathological processes.
- Subjects :
- Acute Disease
Animals
Combined Modality Therapy
Foot pathology
Frostbite pathology
Frostbite physiopathology
Frostbite therapy
Hematologic Agents therapeutic use
Humans
Pentoxifylline pharmacology
Vasodilator Agents pharmacology
Frostbite drug therapy
Pentoxifylline therapeutic use
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0891-8422
- Volume :
- 17
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Clinics in podiatric medicine and surgery
- Publication Type :
- Academic Journal
- Accession number :
- 11070801